Development of Biological Scaffolds for Pediatric Patients having Growth Potential
为具有生长潜力的儿科患者开发生物支架
基本信息
- 批准号:14380419
- 负责人:
- 金额:$ 8.32万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2002
- 资助国家:日本
- 起止时间:2002 至 2005
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
OBJECTIVESTissue engineered grafts based on acellular matrices have been studied to give more durability with growth potential and less immunogenicity to the current bioprostheses. Detergents are commonly used for removal of the cells, whereas the decellularization depends on their permeation in the tissue from its surface and may not be achieved completely in large or hard tissues.METHODSPorcine tissues of the heart valves, aorta, cardiac muscle, skeletal muscle, and trachea were isolated under sterile condition. They were treated immediately by cold isostatic pressing (CIP) of 980 Mpa (10,000 atm) followed by washing at 4℃ (PowerGraft treatment). They were then subjected to histological study, porcine endogeneoua retrovirus (PERV) assay, DNA assay, phospholipids assay, and biomechanical study.RESULTSThe tissues including tracheal cartilage were completely cell free when they were treated by the CIP for 10 min and washing for 7 days. The pressing is applied to the whole of the tissue and no detergents are used in the process. There was no PERV detected from the tissue treated. It has been reported that viruses are mostly inactivated by the CIP more than 600 MPa. The amount of DNA and phospholipids were lower than 1 μg/ml and 0.5 mg/g, respectively. The collagen and elastin fibers were well maintained in the acellular tissue and there were no significant changes in biomechanical properties.CONCLUSIONSPorcine cells and PERV were removed completely in a short period by the PowerGraft treatment. This may have more secure acellular tissues for the tissue regeneration.
已经研究了基于脱细胞基质的工程化移植物,以使目前的生物假体具有更高的耐久性和生长潜力,且免疫原性更低。Determination通常用于去除细胞,而脱细胞依赖于它们从其表面渗透到组织中,并且在大或硬的tissues. METHODS猪组织的心脏瓣膜,主动脉,心肌,骨骼肌和气管在无菌条件下分离。立即通过980 Mpa(10,000 atm)冷等静压(CIP)处理,然后在4℃下清洗(PowerGraft处理)。组织学观察、PERV检测、DNA检测、磷脂检测和生物力学研究结果表明:CIP处理10 min,洗涤7 d,气管软骨等组织完全无细胞。压制应用于整个组织,并且在该过程中不使用清洁剂。在处理的组织中未检测到PERV。据报道,超过600 MPa的CIP可以灭活大多数病毒。DNA含量低于1 μg/ml,磷脂含量低于0.5mg/g。胶原和弹性蛋白纤维在脱细胞组织中保持良好,生物力学性能无明显变化。结论PowerGraft处理可在短时间内完全去除猪细胞和PERV。这可以为组织再生提供更安全的脱细胞组织。
项目成果
期刊论文数量(15)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
藤里俊哉, 西岡 宏, 沼田 智, 庭屋和夫, 岸田晶夫, 中谷武嗣 他: "生体弁の脱細胞化とin vitroでのレシピエント自己細胞化"移植. 38(Suppl). 142 (2003)
Toshiya Fujisato、Hiroshi Nishioka、Satoshi Numata、Kazuo Niwaya、Akio Kishida、Takeshi Nakatani 等:“生物瓣膜脱细胞和体外受体自体细胞化” 移植 38(增刊)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
藤里俊哉, 北村惣一郎: "「再生医療工学の最先端」のうち「心臓弁」"(株)シーエムシー出版. 270 (2002)
藤里俊哉、北村宗一郎:“再生医学工程最前沿的心脏瓣膜” CMC Publishing Co., Ltd. 270 (2002)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
In vitro and in vivo biomechanical properties of decellularized heart valves
脱细胞心脏瓣膜的体外和体内生物力学特性
- DOI:
- 发表时间:2002
- 期刊:
- 影响因子:0
- 作者:Fujisato T;Funamoto S;Hasegawa M;Numata S;Niwaya K;et. al.
- 通讯作者:et. al.
Noyel PVA-DNA nanoparticlesprepared by ultrahigh pressure technology for gene delivery
Noyel PVA-DNA 纳米颗粒采用超高压技术制备用于基因递送
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Kimura T;Okuno A;Miyazaki K;Fujisato T;Kishida A;et. al.
- 通讯作者:et. al.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FUJISATO Toshia其他文献
FUJISATO Toshia的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Understanding the antiviral roles of acellular RNA quality control pathway
了解非细胞 RNA 质量控制途径的抗病毒作用
- 批准号:
10714668 - 财政年份:2023
- 资助金额:
$ 8.32万 - 项目类别:
The role of the inflammatory microenvironment in Acellular Nerve Allografts (ANAs) repairing nerve gaps
炎症微环境在无细胞神经同种异体移植物(ANA)修复神经间隙中的作用
- 批准号:
10678384 - 财政年份:2023
- 资助金额:
$ 8.32万 - 项目类别:
MULTISCALE MODELLING OF ENAMEL DEMINERALISATION AND ACELLULAR REPAIR
牙釉质脱矿和脱细胞修复的多尺度建模
- 批准号:
2739353 - 财政年份:2022
- 资助金额:
$ 8.32万 - 项目类别:
Studentship
Study of the long-term immunogenicity of a combined diphteria, tetanus, acellular pertussis with a Sabin strain derived inactivated poliovirus vaccine
白喉、破伤风、无细胞百日咳联合沙宾株灭活脊髓灰质炎病毒疫苗的长期免疫原性研究
- 批准号:
22K17345 - 财政年份:2022
- 资助金额:
$ 8.32万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acellular composite hydrogel scaffolds for volumetric muscle regeneration
用于体积肌肉再生的脱细胞复合水凝胶支架
- 批准号:
10372733 - 财政年份:2022
- 资助金额:
$ 8.32万 - 项目类别:
Acellular composite hydrogel scaffolds for volumetric muscle regeneration
用于体积肌肉再生的脱细胞复合水凝胶支架
- 批准号:
10835331 - 财政年份:2022
- 资助金额:
$ 8.32万 - 项目类别:
Acellular composite hydrogel scaffolds for volumetric muscle regeneration
用于体积肌肉再生的脱细胞复合水凝胶支架
- 批准号:
10555267 - 财政年份:2022
- 资助金额:
$ 8.32万 - 项目类别:
Control of cochlear amplification by cellular and acellular elements of the mammalian cochlea
哺乳动物耳蜗的细胞和非细胞元件对耳蜗放大的控制
- 批准号:
MR/W028956/1 - 财政年份:2022
- 资助金额:
$ 8.32万 - 项目类别:
Research Grant
Are acellular vaccines driving the rise of pertactin-deficient Bordetella pertussis
无细胞疫苗是否会导致缺乏百日咳博德特氏菌的增加
- 批准号:
10364771 - 财政年份:2021
- 资助金额:
$ 8.32万 - 项目类别:
PHMB-Impregnated Acellular Biologic Grafts for Treatment of Third-Degree Burns
PHMB 浸渍的脱细胞生物移植物用于治疗三度烧伤
- 批准号:
10338915 - 财政年份:2021
- 资助金额:
$ 8.32万 - 项目类别: